NO20065321L - Fremgangsmate for fremstilling av clopidogrelhydrogensulfat polymorf for I - Google Patents

Fremgangsmate for fremstilling av clopidogrelhydrogensulfat polymorf for I

Info

Publication number
NO20065321L
NO20065321L NO20065321A NO20065321A NO20065321L NO 20065321 L NO20065321 L NO 20065321L NO 20065321 A NO20065321 A NO 20065321A NO 20065321 A NO20065321 A NO 20065321A NO 20065321 L NO20065321 L NO 20065321L
Authority
NO
Norway
Prior art keywords
preparation
hydrogen sulfate
clopidogrel hydrogen
sulfate polymorph
polymorph
Prior art date
Application number
NO20065321A
Other languages
English (en)
Other versions
NO339878B1 (no
Inventor
Haifang Mao
Hongguang Qian
Chen Chen
Original Assignee
Krka Tovarna Zdravil Dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 200410009028 external-priority patent/CN1690060A/zh
Priority claimed from SI200400122A external-priority patent/SI21749A/sl
Application filed by Krka Tovarna Zdravil Dd filed Critical Krka Tovarna Zdravil Dd
Publication of NO20065321L publication Critical patent/NO20065321L/no
Publication of NO339878B1 publication Critical patent/NO339878B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

Det er beskrevet fremgangsmåter for fremstilling av klopridogrelhydrogensulfat av polymorf form I, disse omfatter anvendelse av spesifikke løsningsmidler og fremgangsmåtetrekk for å unngå dannelsen av uønskede biprodukter.
NO20065321A 2004-04-19 2006-11-20 Fremgangsmåte for fremstilling av clopidogrelhydrogensulfat polymorf form I NO339878B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN 200410009028 CN1690060A (zh) 2004-04-19 2004-04-19 一种制备i型硫酸氯吡格雷的方法
SI200400122A SI21749A (sl) 2004-04-21 2004-04-21 Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata
PCT/EP2005/004160 WO2005100364A1 (en) 2004-04-19 2005-04-19 Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form i

Publications (2)

Publication Number Publication Date
NO20065321L true NO20065321L (no) 2007-01-09
NO339878B1 NO339878B1 (no) 2017-02-13

Family

ID=34965241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065321A NO339878B1 (no) 2004-04-19 2006-11-20 Fremgangsmåte for fremstilling av clopidogrelhydrogensulfat polymorf form I

Country Status (10)

Country Link
US (1) US7999106B2 (no)
EP (1) EP1740593B1 (no)
EA (1) EA010198B1 (no)
ES (1) ES2577303T3 (no)
HR (1) HRP20160757T1 (no)
HU (1) HUE029459T2 (no)
NO (1) NO339878B1 (no)
PL (1) PL1740593T3 (no)
SI (1) SI1740593T1 (no)
WO (1) WO2005100364A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772398B2 (en) * 2005-03-11 2010-08-10 Dr. Reddy's Laboratories, Inc. Process for making crystalline form I of clopidogrel hydrogen sulphate
US20090093635A1 (en) * 2006-03-09 2009-04-09 Sandor Garadnay PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
WO2008032995A1 (en) * 2006-09-15 2008-03-20 Boryung Pharmaceutical Co., Ltd Clopidogrel(+)-camphorsulfonate salt, method of preparing the same and a pharmaceutical composition comprising the same
SI22383A (sl) * 2006-09-22 2008-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
WO2008068569A2 (en) * 2006-12-01 2008-06-12 Wockhardt Research Centre Processes for the preparation of clopidogrel hydrochloride
EP2114957A4 (en) * 2007-01-29 2011-06-08 Ipca Lab Ltd PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM 1 OF A CLOPIDOGREL HYDROGEN SULFATE
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
EP2107061A1 (en) * 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
WO2011042804A2 (en) 2009-10-08 2011-04-14 Jubliant Life Sciences Limited An improved process for the preparation of clopidogrel hydrogen sulfate form i
WO2011051976A2 (en) * 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of clopidogrel bisulfate form i
WO2011125069A1 (en) * 2010-03-22 2011-10-13 Rpg Life Sciences Limited A process for preparation of crystalline form i of clopidogrel bisulfate
CN103360406A (zh) * 2012-03-26 2013-10-23 黑龙江福和华星制药集团股份有限公司 一种制备i型硫酸氢氯吡格雷的方法
CN102924474B (zh) * 2012-11-08 2015-04-01 浙江海翔药业股份有限公司 一种氯吡格雷硫酸氢盐晶型ⅰ的制备方法
KR102626155B1 (ko) 2015-03-06 2024-01-17 비욘드스프링 파마수티컬스, 인코포레이티드. Ras 돌연변이와 관련된 암의 치료 방법
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
CA2989431C (en) 2015-06-17 2023-08-29 Franklin Bymaster Crystalline compounds
US10912748B2 (en) 2016-02-08 2021-02-09 Beyondspring Pharmaceuticals, Inc. Compositions containing tucaresol or its analogs
EP3565812B1 (en) 2017-01-06 2023-12-27 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
JP2020514412A (ja) 2017-02-01 2020-05-21 ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド 好中球減少症の低減方法
WO2018149608A1 (en) 2017-02-16 2018-08-23 Sandoz Ag Crystalline forms of cabotegravir sodium
WO2019147615A1 (en) 2018-01-24 2019-08-01 Beyondspring Pharmaceuticals, Inc. Composition and method for reducing thrombocytopenia via the administration of plinabulin
TW202028208A (zh) 2018-10-09 2020-08-01 瑞士商諾華公司 N-(4-氟-3-(6-(3-甲基吡啶-2-基)-[1,2,4]***并[1,5-a]嘧啶-2-基)苯基)-2,4-二甲基㗁唑-5-甲醯胺固體形式

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
WO2002018357A1 (en) 2000-08-29 2002-03-07 Rpg Life Sciences Limited A ONE-POT PROCESS FOR THE PREPARATION OF PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS OF 4, 5, 6, 7 - TETRAHYDROTHIENO (3,2-c) PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY
GB0125708D0 (en) 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
ES2316650T3 (es) * 2001-12-18 2009-04-16 Teva Pharmaceutical Industries Ltd. Polimorfos de hidrogenosulfato de clopidogrel.
CZ297472B6 (cs) 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
CN1325491C (zh) 2002-08-27 2007-07-11 安斯泰来制药有限公司 新颖结晶
AU2003285841A1 (en) * 2002-11-28 2004-06-18 Anpharm Przedsiebiorstwo Farmaceutyczne S.A. A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
EP1603920A1 (en) * 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
CZ200641A3 (cs) 2003-07-02 2006-05-17 EGIS Gyógyszergyár Rt. Zpusob prípravy krystalického polymorfu inhibitoru srázení krevních desticek
EP1651646B1 (en) 2003-08-04 2012-05-09 Wockhardt Limited A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i
DE10337773A1 (de) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Kristallisation von festen Formen von Clopidogrel-Additionssalzen
US7629465B2 (en) * 2004-03-05 2009-12-08 Ipca Laboratories Ltd. Industrial process for preparation of Clopidogrel hydrogen sulphate

Also Published As

Publication number Publication date
SI1740593T1 (sl) 2016-08-31
EP1740593A1 (en) 2007-01-10
PL1740593T3 (pl) 2016-09-30
WO2005100364A1 (en) 2005-10-27
EA010198B1 (ru) 2008-06-30
EP1740593B1 (en) 2016-04-06
EA200601822A1 (ru) 2007-02-27
US7999106B2 (en) 2011-08-16
HUE029459T2 (en) 2017-02-28
NO339878B1 (no) 2017-02-13
HRP20160757T1 (hr) 2016-08-12
US20090234123A1 (en) 2009-09-17
ES2577303T3 (es) 2016-07-14

Similar Documents

Publication Publication Date Title
NO20065321L (no) Fremgangsmate for fremstilling av clopidogrelhydrogensulfat polymorf for I
DE60230327D1 (de) Polymorphe von clopidogrel-hydrogensulfat
NO20075809L (no) DNA-PK inhibitorer
WO2006099468A3 (en) Process for the purification of duloxetine hydrochloride
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
WO2006066950A3 (de) Tricyclische aminoalkohole, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE602004013405D1 (de) Polymorphe formen von valsartan
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
HK1150597A1 (no)
EP1829868A4 (en) PROCESS FOR PRODUCING (4,5-DIHYDROISOXAZOL-3-YL) THIOCARBOXAMIDINE SALTS
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
MY144180A (en) Method for producing strontium ranelate and its hydrates
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
WO2005080403A3 (en) Chemical process
NO20050885D0 (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
HK1105968A1 (en) Process for production of 3-alkenylcephem compounds 3-
WO2006122020A3 (en) Process for production of 4-biphenylyazetidin-2-ones
DK1501838T3 (da) Fremgangsmåde til fremstilling af clopidogrel
GB0402262D0 (en) Process for the manufacture of organic compounds
WO2008004249A3 (en) An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
EP1801228A4 (en) METHOD FOR PRODUCING ENANTIOMENE-ENRICHED COMPOUNDS
TW200730524A (en) Process for making heteroaryl amine intermediate compounds
TW200708507A (en) A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees